Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Warren

Showing results (691-700 of 910) with videos related to

Pageof 91
Sort By:
Clinical and Experimental Dermatology|October 19, 2024
Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Kerry Williams, Georgia Lada, Nick J Reynolds, et al.
Cells|September 8, 2023
Human Mast Cells Upregulate Cathepsin B, a Novel Marker of Itch in PsoriasisPeter W West, Chiara Tontini, Haris Atmoko, et al.
The British Journal of Dermatology|April 8, 2017
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort studyN J Davison, R B Warren, K J Mason, et al.
The Journal of Investigative Dermatology|November 13, 2013
Polymorphisms in IL-1B distinguish between psoriasis of early and late onsetHarry L Hébert, John Bowes, Rhodri L Smith, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 4, 2025
Hidradenitis suppurativa with and without draining tunnels: A real-world study characterizing differences in treatment and disease burdenJ R Ingram, A V Marzano, E Prens, et al.
The British Journal of Dermatology|December 5, 2023
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
JAMA Dermatology|December 2, 2020
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators RegisterZenas Z N Yiu, Kayleigh J Mason, Philip J Hampton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2022
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tabletsRichard B Warren, Bruce Strober, Jonathan I Silverberg, et al.
Archives of Dermatological Research|June 11, 2013
Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis--a multinational cross-sectional studyA Nast, U Mrowietz, K Kragballe, et al.
Nature Genetics|December 1, 1995
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidismC Ho, D A Conner, M R Pollak, et al.
Pageof 91

Showing results (691-700 of 910) with videos related to

Sort By:
Pageof 91
Clinical and Experimental Dermatology|October 19, 2024
Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Kerry Williams, Georgia Lada, Nick J Reynolds, et al.
Cells|September 8, 2023
Human Mast Cells Upregulate Cathepsin B, a Novel Marker of Itch in PsoriasisPeter W West, Chiara Tontini, Haris Atmoko, et al.
The British Journal of Dermatology|April 8, 2017
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort studyN J Davison, R B Warren, K J Mason, et al.
The Journal of Investigative Dermatology|November 13, 2013
Polymorphisms in IL-1B distinguish between psoriasis of early and late onsetHarry L Hébert, John Bowes, Rhodri L Smith, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 4, 2025
Hidradenitis suppurativa with and without draining tunnels: A real-world study characterizing differences in treatment and disease burdenJ R Ingram, A V Marzano, E Prens, et al.
The British Journal of Dermatology|December 5, 2023
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
JAMA Dermatology|December 2, 2020
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators RegisterZenas Z N Yiu, Kayleigh J Mason, Philip J Hampton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2022
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tabletsRichard B Warren, Bruce Strober, Jonathan I Silverberg, et al.
Archives of Dermatological Research|June 11, 2013
Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis--a multinational cross-sectional studyA Nast, U Mrowietz, K Kragballe, et al.
Nature Genetics|December 1, 1995
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidismC Ho, D A Conner, M R Pollak, et al.
Pageof 91